Sneddon Syndrome: Livedo Reticularis And Ischemic Stroke

MUSTAFA ALTAŞ, AHMET BUĞRUL, HASAN HÜSEYİN KOZAK

  • Year : 2021
  • Vol : 37
  • No : 1
  •  Page : 80-82

Sneddon syndrome(SS) is a rare, progressive vasculopathy with recurrent ischemic attacks. There is no specified treatment recommendation, various treatment methods such as anticoagulants, antiaggregants, and immunosuppressions are recommended. A 44-years-old woman who applied with a temporary numbness on her right side and speech disorder. In her neurological examination, there was central facial asymmetry on the right and mild dysarthria in his speech. In cranial diffusion MR, there was an acute ischemic change in the left lentiform nucleus and at the head of the caudate nucleus. In cranial MR, there were perivascular ischemic gliotic changes and diffuse cerebral cortical atrophy. The patient underwent a skin biopsy to have livedo reticularis-like lesions on both legs. Skin biopsy was compatible with vasculopathy. Due to the ischemic attack, periventricular ischemic changes, and livedoreticularis, the patient was accepted as SS. Since the antiphospholipid antibodies (APL) were negative, that she was followed up with dual antiplatelet therapy. There was no new attack within a year with dual therapy. Dual antiplatelet therapy may be used in SS patients with recurrent ischemic events and negative APL.                                                                                                                                           

Cite this Article As : Bugrul A, Kozak, HH, Altas M. Sneddon Syndrome: Livedo Reticularis and Ischemic Stroke. Selcuk Med J 2021;37(1): 80-82
Description : None of the authors, any product mentioned in this article, does not have a material interest in the device or drug. Research, not supported by any external organization. grant full access to the primary data and, if requested by the magazine they agree to allow the examination of data.
Sneddon Syndrome: Livedo Reticularis And Ischemic Stroke
, Vol. 37 (1)
Received : 16.11.2020, Accepted : 16.11.2020, Published Online : 04.03.2021
Selçuk Tıp Dergisi
ISSN:1017-6616;
E-ISSN:2149-8059;